If you’re looking at treatment options for heart failure, you may want to learn more about Entresto (sacubitril/valsartan). It’s a prescription drug used to treat ...

Entresto is a brand-name prescription medication containing sacubitril and valsartan. The FDA approved generic versions of Entresto in May 2024, and the drug was launched in July 2025. According to ...

FDA plea aside, Novartis is involved in litigation with several generic drugmakers in a bid to delay Entresto copycats. (Photo by SEBASTIEN BOZON/AFP via Getty Images) As blockbuster heart failure ...

New Trump tariffs on pharmaceuticals could double the cost of common prescription drugs, raising prices for medications like ...

Novartis was unsuccessful in convincing a federal court to block MSN Pharmaceuticals from introducing its own version of Novartis' heart-failure drug Entresto, according to a court decision issued on ...

The Third Circuit and Federal Circuit this week turned back Novartis’s requests for injunctions to block a version of its heart failure medication Entresto from generic maker MSN ...

A new suit against Novartis comes as the Swiss pharma is trying to fend off several Entresto generic contenders with lawsuits. (Novartis) Novartis is already suing a long list of generics producers ...

Novartis wasn't successful in convincing a U.S. appeals court to stop MSN Pharmaceuticals' proposed generic of Novartis' Entresto, per a Reuters report. The U.S. Court of Appeals for the Federal ...

Anyone on the heart failure drug Entresto who tests positive for Alzheimer’s disease based on blood Aβ42/40 might not want to panic. That’s because the drug can lower the amyloid ratio three times ...

There’s good news in 2026 for seniors enrolled in Medicare Part D who rely on the priciest prescription drugs: 10 high-cost ...

FRANKFURT, July 18 (Reuters) - Swiss drugmaker Novartis (NOVN.S), opens new tab raised its 2024 earnings guidance for the second time on Thursday, driven by a gain in prescriptions for drugs including ...